^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SimpleScreen™ CRC blood test

    Company:
    Freenome
    Type:
    FDA Approved (PMA)
    Related tests:
    Details
    Evidence

    News

    4ms
    Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer (Freenome Press Release)
    "Freenome...today announced an exclusive license agreement with Exact Sciences to advance the commercialization of its colorectal (CRC) blood-based screening test,* including the U.S. commercial rights and the underlying technology. Freenome retains the rights for its CRC blood test when it is ordered in combination with additional cancer screening tests, including for lung and more than 10 other initial cancer indications the company is pursuing...Final module for the first version of Freenome’s colorectal cancer test has been submitted to FDA; approval and commercial launch anticipated in 2026"
    FDA approval • Commercial
    |
    SimpleScreen™ CRC blood test